A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838

NCT01510899 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: RO4917838
DRUG: RO4917838

Sponsor

Hoffmann-La Roche